1. S Oie, YH Kao Yang. Effect of altered albumin concentrations on elimination of
unbound prazosin in vivo in the rat and in the isolated perfused rat liver. J Pharm Sci.
1. YH Kao Yang, CY Yang, JD Huang. Mesenteric Clearance of 5-fluorouracil in
anesthetized rats. J Pharm Sci. 1987;76:86.
1. YH Kao Yang. Clarifying the observations of a traveling pharmacist. Am J Hosp
Pharm. 1986;43:2398.
1. YH Kao Yang, CY Yang, J.D. Huang. Pulmonary elimination of 5-fluorouracil in
anesthetized rats. J Pharm Sci. 1985;74:1095.
2. JD Huang, YH Kao Yang. Bioequivalency of two brands of tobramycin. J Taiwan
Pharm Assoc. 1985;37:146.
3. CS Chen, YH Kao Yang, SL Pan. The HPLC assay of indirubin in ‘Qingdai’ and Chinese herbal formulae. J Taiwan Pharm Assoc. 1985;37:136.
4. CY Yang, YH Kao Yang, J.D. Huang. Comparison of serum creatining levels
determined by HPLC and automated analysis. J Taiwan Pharm Assoc. 1985;37:217.
1. CS Liu, LL Hsieh, Y.H. Kao Yang, RR Chen. The bioequivalency of three brands of ampicillin capsules: pentrexyl, ancillin and ampolin. J Taiwan Pharm Assoc. 1982;34:65.
2. RR Chen, LL Hsieh, YH Kao Yang, ZP Chen. Cefoperazone pharmacokinetics in
healthy Chinese volunteers. J Taiwan Pharm Assoc. 1982;34:121.


1. YH Kao Yang, SH Hsiao, PW Lin, TJ Wu. Surveillance of adverse drug reactions from
intravenous fat emulsions in a surgical ward. The Chin Pharm J. 1999;51:365-73.
2. YH Kao Yang, LC Chen, KWA Chan, ML Lai. Changes in ticlopidine utilization
pattern after educational intervention. The Chin Pharm J. 1999;51:347-58.
3. 許美英、高雅慧、楊俊佑。環氧化酵素與非類固醇抗發炎藥物的新進展。台灣醫
1. 林佩津、高雅慧。Fluoroquinolones在肺結核與骨髓炎治療上之角色。台灣醫學
2. YH Kao Yang, SM Kao and KW A Chan. A retrospective drug utilization evaluation of
antihyperlipidaemic agents in a medical centre in Taiwan. J Clin Pharm Ther.
1. JR Wu, FY Yeh Liu, LM Tsai, YH Kao Yang. Torsade de pointes induced by
astemizole combined with ketoconazole – a case report. Cont Med Edu. 1996;6:40-6.
2. SM Kao, YH Kao Yang. Hyperlipidemia and drug therapy. Cont Med Edu.
1. JH Jan Chern, YH Kao Yang. Pilocarpine: A clinical potential in xerostomia. Cont
Med Edu. 1995;5:661-6.
2. YC Yang, SA Chung, YH Kao Yang, SC Huang, CJ Chang. A pilot study of health
education on hypertension given by pharmacists in the community. Chin J Fam Med.
3. CD Yang, YH Kao Yang. Antihistamines. Cont Med Edu. 1995;5:79-86.
1. YH Kao Yang, HC Yang. Drug utilization review of essential amino acid injection. J Clin Pharm Assoc. 1994;3:91-8.
1. JH Jan, CD Yang, YH Kao Yang. Teratogenicity consultation services. J Clin Pharm
Assoc. 1993;2:73.
2. FJ Hsu, JJ Hsue, YH Kao Yang. Design and evaluation of metered dose inhaler
education program in patients with chronic obstructive pulmonary disease. J Clin
Pharm Assoc. 1993;2:S 31.
1. JH Jan, YH Kao Yang. Antithyroid drug of choice among pregnant women. J Clin
Pharm Assoc. 1992;1:75.
2. CY Lin, YH Kao Yang . Combination use of lovastatin and gemfibrozil – appropriate
or not? J Clin Pharm Assoc. 1992;1:79.
3. YC Wu, YH Kao Yang. Clinical pharmacy services in the rehabilitation ward at
National Cheng Kung University Hospital. J Clin Pharm Assoc. 1992;1:S18.
4. JR Wu, YH Kao Yang. A survey of the medication uses in diabetic patients. J Clin
Pharm Assoc. 1992;1:29.
5. JJ Tsai, ML Lai, YH Kao Yang, JD Huang. Comparison on bioequivalence of four
phenytoin preparations in patients with multiple dose treatment. J Clin Pharmacol.


Liu YM, Yang Kao YH, Hsieh CR. Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. Journal of Health Economics 2009:28 (2):341-349
Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Yang Kao YH. Guideline compliance in antithrombotic treatment of atrial fibrillation patients – A nationwide study in Taiwan. Clinical Therapeutics. 2008;30:1726-1736.
Lin TL, Yang Kao YH, Tang CH, Wu HM, Cheng HW. Impact of Introduction of Angiotensin II Antagonist on the Antihypertensive Utilization in Taiwan. J Food Drug Analysis 2008;16:21-29.

Liu YM, Yang Kao YH, Hsieh CR. Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. Journal of Health Economics 2009:28 (2):341-349
Li YH, Wu HL, Yang Kao YH, Tsai HS, Chao TH. Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndrome. Int Heart J. 2007;48(6):677-88.
陳珮甄、高雅慧、許美英。胰島素過敏。台灣醫學 2007;11:580-4.
黄千惠、王明誠、廖麗香、高雅慧。Statin在慢性腎病患者的角色。台灣醫學 2007;11:438-44.
楊雅雯、廖麗香、高雅慧。產前類固醇在預防早產兒呼吸窘迫症候群之應用。台灣醫學 2007;11:320-7.
Lin TL, Yang Kao YH, Tang CH, Wu HM, Cheng HW. An economic evaluation on the pharmaceutical expenditure of antihypertensive agents in Taiwan from 1997 to 2002. J Food Drug Analysis 2007;15:233-41.
翁德昌、葉鳳英、高雅慧。Sirolimus塗藥支架之應用。台灣醫學 2007;11:216-23.
翁德昌、蔡慧珊、高雅慧。血管張力素轉化酶抑制劑在血清肌酸酐及血鉀升高病患之使用。台灣醫學 2007;11:104-9.
Yang SY, Yang Kao YH*, Chong MY, Yang YH, Chang WH, Lai CS. Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study. Clinical Pharmacology & Therapeutics 2007;81:586-94.
林慧玲、許光陽、闕壯卿、李安榮、簡伯武、高雅慧等。2005年台灣藥學教育白皮書。醫學教育 2006;10:165-85.
陳珮甄、張家銘、高雅慧、蔡慧珊。老年人使用每日一次胺基醣苷類抗生素之腎毒性相關危險因子﹒台灣老年醫學雜誌 2006;1:216-25.
翁德昌、程盟夫、黃建鐘、王德華、李玉雲、吳玉琴、高雅慧。類固醇對於allopurinol過敏症候群治療成效-病例報告。內科學誌 2006;17:133-40.
Huang YM, Wang HP, Yang Kao YH, Lin SJ, Lin HW, Chen CS, Wu FLL. Effects of a national health education program on the medication knowledge of the public in Taiwan. Annals of Pharmacotherapy, 2006; 40:102-108.
SJ Lin, SC Kuo, YH Kao Yang. Appeals system and its outcomes in National Health Insurance in Taiwan. Ann Pharmacother. 2006;40(3):506-11
Lin WT, Yang Kao YH, Kuo SC, Sung JM, Chen FF, Huang JJ. Low-dose mycophenolate mofetil therapy for Taiwanese with refractory glomerulonephritis –Emphasize the effect on membranous nephropathy. Acta Nephrologica 2006;20:90-7.
杜安琇、葉鳳英、高雅慧。Azathioprine引起的單純紅血球再生不良。台灣醫學 2006;10:42-8.
洪永潤、許美英、王明誠、高雅慧。以基因重組工程紅血球生成素治療癌症病患之貧血。台灣醫學 2006;10:256-9.

1. 張筱琳、高雅慧、高淑敏、王明誠、曾進忠。鈣離子通道阻斷劑在慢性腎疾病的
角色。內科學誌 2005;16:175-180.
2. H Sun, KY Lue, YH Kao Yang. Prescribing patterns of anti-asthma drugs in pediatric
patients. Acta Paediatrica Taiwanica. 2005;46(4):212-8.
3. CM Chang, PY Yeh Liu, YH Kao Yang, YC Yang, CF Wu, FH Lu. Use of the Beers
criteria to predict adverse drug reactions among first-visit elderly outpatients.
Pharmacotherapy 2005;25(6):831-8.
4. S.C. Kuo, Y.H. Kao Yang. Confounders of uric acid levels [letter]. Arch Intern Med.
5. 黃郁淳、郭士禎、顏家瑞、高雅慧。全身性合併化學療法對一例肝癌轉移之治療。
台灣醫學 2005;9:39-46.


Chen JS, Chang CH, Yang WH, Kao YH. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study. BJU Int. 2012; 110(11 Pt C):E896-901.
Yang YH, Yang YH, Cheng CL, Ho PS, Ko YC. The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients – a population-based study. BMC Cancer. 2012 Dec 6;12:582.
Liu YM, Yang YH, Hsieh CR. Regulation and competition in the Taiwanese pharmaceutical market under national health insurance. J Health Econ. 2012 Mar 21;31(3):471-483.
Lee CH, Cheng CL, Chang CH, Kao Yang YH, Lin LJ, Lin TC, Yang CY. Universal Pharmacological Thromboprophylaxis for Total Knee Arthroplasty May Not be Necessary in Low Risk Populations: a Nationwide Study in Taiwan. J Thromb Haemost 2012;10: 56–63.
Kimura T, Matsushita Y, Yang YH, Choi NK, Park BJ. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan. Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1237-45.
Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YH, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation 2011;15:2233-42
Lee CH, Cheng CL, Lin LJ, Tsai LM, Yang Kao YH. Epidemiology and Predictors of Short-term Mortality in Symptomatic Venous Thromboembolism – A Nationwide Population-based Study. Circulation Journal 2011;75:1998-2004
Cheng CL, Chen YC, Liu TM, Yang Kao YH. Using Spatial Analysis to Demonstrate the Heterogeneity of the Cardiovascular Drug-Prescribing Pattern in Taiwan. BMC Public Health. 2011 May 24;11(1):380.
Lin TC, Yang Kao YH, Yang CY, Lin SJ. The compliance to Alendronate and its impact of hip fracture risk among established osteoporosis patients in Taiwan. Clinical Pharmacology and Therapeutics 2011;90:109-116
Liu YM, Yang Kao YH, Hsieh CR. The determinants of the adoption of pharmaceutical innovation: Evidence from Taiwan. Social Science & Medicine 2011; 72: 919-927
Cheng CL, Yang Kao YH, Lin SJ, Lee CH and Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiology and drug safety 2011 ; 20: 236-242
Lee CH, Lin LJ, Cheng CL, Yang Kao YH, Chen JY, Tsai LM. Incidence and cumulative recurrent rates of venous thromboembolism in the Taiwanese population. Journal of Thrombosis and Haemostasis 2010; 8: 1515–1523
Cheng CL, Yang Kao YH, Lin SJ, Lin CH, Lin YJ. Compliance with Dosing Recommendations from Common References in Antibiotic Prescriptions for Preterm Neonates. Pharmacoepidemiology and Drug Safety 2010;19(1):51-8
Weng TC, Yang Kao YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic equivalence of statins. Journal of Clinical Pharmacy and Therapeutics. 2010;35(2):139-151.
Liu YM, Yang Kao YH. Hospital competition and prescribing behaviors: empirical evidence from Taiwan. Journal of Developing Areas 2010;43:125-41


Lin TC, Lee CH, Yang CY, Yang YH, Lin SJ. Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments. J Clin Endocrinol Metab. 2014;99(5):1599-607.
Lai EC, Hsieh CY, Kao Yang YH, Lin SJ. Detecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysis. PLoS One. 2014 Feb 27;9(2):e89795.
Lin TC, Yang CY, Kao Yang YH, Lin SJ. Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population. Osteoporosis International. 2014;25(5):1503-11.
Chang CH, Wang YW, Yeh Liu PY, Kao Yang YH. A practical approach to minimize the interaction of dietary vitamin K with warfarin. J Clin Pharm Ther. 2014 Feb;39(1):56-60. doi: 10.1111/jcpt.12104. Epub 2013 Oct 28.
Lai EC, Kao Yang YH, Kuo HC. Complication rate of neurogenic lower urinary tract dysfunction after spinal cord injury in Taiwan. Int Urol Nephrol. 2013 Dec 18. [Epub ahead of print]
Cheng CL, Chao PH, Hsu JC, Weng MM, On AW, Yang YH. Utilization patterns of Antihyperuricemic Agents Following Safety Announcement on Allopurinol and Benzbromarone by Taiwan Food and Drug Administration. Pharmacoepidemiol Drug Saf. 2013 Dec 5. doi: 10.1002/pds.3550. [Epub ahead of print]
Lin TC, Yang CY, Yang YH, Lin SJ. Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women. J Clin Endocrinol Metab. 2013;98(12):4717-26.
Lai EC, Yang YH, Lin SJ, Hsieh CY. Use of antiepileptic drugs and risk of hypothyroidism. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1071-9. doi: 10.1002/pds.3498. Epub 2013 Aug 15.
Hsieh CY, Chen CH, Chen YC, Kao Yang YH. National Survey of Thrombolytic Therapy for Acute Ischemic Stroke in Taiwan 2003-2010. J Stroke Cerebrovasc Dis. 2013 Oct 11. doi:pii: S1052-3057(13)00326-1.
Lee CH, Lin TC, Cheng CL, Yang CY, Lin LJ, Kao Yang YH. Comparative risk of venous thromboembolism between total knee and hip replacement – a 10-year nationwide population-based study in Taiwan. J Thromb Haemost. 2013 Aug 12. [Epub ahead of print]
Chen PS, Cheng CL, Kao Yang YH, Yeh PS, Li YH. Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack. Acta Neurol Scand. 2013 Jun 13. [Epub ahead of print]
Cheng CL, Kao Yang YH, Liu CC, Lee PI. A retrospective study on the usage of cough and cold medications in viral respiratory tract infections in Taiwanese children. 2013 May 27. [Epub ahead of print]
Cheng-Yang Hsieh, Edward Chia-Cheng Lai, Yea-Huei Kao Yang, Swu-Jane Lin. Comparative stroke risk of antiepileptic drugs in patients with epilepsy. Epilepsia 2013; 54(1):172-80.
Chang CH, Yang YH, Lin SJ, Su JJ, Cheng CL, Lin LJ. Risk of insomnia attributable to β-blockers in elderly patients with newly diagnosed hypertension. Drug Metab Pharmacokinet. 2013;28(1):53-8.
Edward Chia-Cheng Lai, Chia-Hsien Chang, Yea-Huei Kao Yang, Swu-Jane Lin, Chia-Yin Lin. Effectiveness of Sulpiride in Adult Patients with Schizophrenia. Schizophrenia Bulletin. 2013;39(3):673-83